ouabain has been researched along with olprinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroki, J; Ogawa, T; Ohhara, H; Shoji, T; Tsunoda, H | 1 |
| Alpert, NR; Hasenfuss, G; Holubarsch, C; Just, H | 1 |
2 other study(ies) available for ouabain and olprinone
| Article | Year |
|---|---|
Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
Topics: Adrenergic beta-Antagonists; Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Guinea Pigs; Heart; Heart Rate; Hemodynamics; Histamine H2 Antagonists; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Phosphoric Diester Hydrolases; Pyridones; Sodium-Potassium-Exchanging ATPase | 1989 |
Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain.
Topics: Adrenergic beta-Agonists; Animals; Deoxyepinephrine; Guinea Pigs; Hot Temperature; Imidazoles; In Vitro Techniques; Muscle Contraction; Ouabain; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical | 1994 |